A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Ulcerative Colitis

  • Leong, Rupert (Primary Chief Investigator)
  • Chapman, Nicola, (Clinical Trial Unit Staff)
  • Parshionikar, Abhijit, (Clinical Trial Unit Staff)
  • Rajasekharan Nair, Archana, (Clinical Trial Unit Staff)

Project: Other

Project Details

Effective start/end date17/12/1924/09/24